Viridian Therapeutics Inc (VRDN)

Finanzdaten der Viridian Therapeutics Inc-Aktie (VRDN)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.00% 0.072	0.072	0.072	0.072	0.098
Operating Expenses	21.78% 55.97	71.55	51.30	59.35	72.57
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	21.78% 55.97	71.55	51.30	59.35	72.57
Operating Income/Loss	21.80% -55.90	-71.48	-51.22	-59.27	-72.47
Nonoperating Income/Loss	59.27% 7.355	4.618	3.564	4.212	4.322
Income/Loss From Continuing Operations Before Tax	0.00% 0.072	0.072	0.072	-55.06	-68.15
Income/Loss From Continuing Operations After Tax	27.40% -48.54	-66.86	-47.66	-55.06	-68.15
Net Income/Loss	27.40% -48.54	-66.86	-47.66	-55.06	-68.15
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,499% 61.10	1.6978	43.65	43.25	42.24
Diluted Average Shares	3,499% 61.10	1.6978	43.65	43.25	42.24
Basic Earnings Per Share	41.04% -0.79	-1.34	-1.09	-1.27	-1.61
Diluted Earnings Per Share	41.04% -0.79	-1.34	-1.09	-1.27	-1.61
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-